Institutional investors purchased a net $288.2 thousand shares of JNP during the quarter ended March 2015 and now own 27.11% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BELLEVUE ASSET MANAGEMENT AG Bought 110.0 Thousand shares of Juniper Pharmaceuticals I...